Article

August 26, 2014

New Head of Healthcare.gov Is Connecticut's Counihan

Kevin Counihan, the head of Connecticut's health insurance marketplace, will be the new CEO of healthcare.gov, the website that 36 states use to sell Affordable Care Act insurance, the administration announced at noon today.

Kevin Counihan, the head of Connecticut's health insurance marketplace, will be the new CEO of healthcare.gov, the website that 36 states use to sell Affordable Care Act insurance, the administration

at noon today.

Department of Health and Human Services Secretary Sylvia Burwell tapped Counihan to lead the site as part of a

that aims to have the second year of Obamacare run more smoothly than the first.

Source: Kaiser Health News

Read the full story:

revamped management structure

http://bit.ly/XPA4dY

Related Videos

John Michael O'Brien, PharmD, MPH

4 experts are featured in this series.

5 experts are featured in this series

5 experts are featured in this series

Richard J. Nowak, MD, MS, Yale School of Medicine

4 experts are featured in this series.

Naim Alkhouri, MD

Christine Funke, MD

Related Content

NYOH’s Doyle on Joining OneOncology: What We Value the Most Is Culture

April 25th 2025

NYOH’s Doyle on Joining OneOncology: What We Value the Most Is Culture

New York Oncology and Hematology becomes the 27th practice in OneOncology.

April 22nd 2025

New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix

Brooke McCormick Brady Post, PhD

On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.

Tailored approaches help patients with MM find the regimen that works best for them, which improves quality of life and outcomes | image credit: Dzmitry - stock.adobe.com

April 25th 2025

Tailored Dosing for MM Matters More Than Drug Count: Ajai Chari, MD

Kyle Munz Ajai Chari, MD

When it comes to treating multiple myeloma (MM), Ajai Chari, MD, argued that more is not always better. More intense treatment regimens, or those with more drugs, don't necessarily guarantee better outcomes.

Managed Care Cast Thumbnail

April 15th 2025

Personalized Care Key as Tirzepatide Use Expands Rapidly

Maggie L. Shaw John W. Ostrominski, MD

Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.

US Tariffs | Image credit: Andrii - stock.adobe.com

April 25th 2025

Trump Tariffs on Pharmaceuticals Risk Causing Higher Costs, Drug Shortages

The Trump administration is proceeding with probes into the national security implications of pharmaceutical imports.

Anatomy of colon model | Image credit: M+Isolation+Photo - stock.adobe.com

April 24th 2025

TyG-BMI Index Predicts Colorectal Cancer Risk, Study Finds

A new analysis links higher triglyceride-glucose (TyG) and TyG–body mass index (TyG-BMI) levels to increased colorectal cancer (CRC) risk, especially among women, but not mortality.

Related Content

NYOH’s Doyle on Joining OneOncology: What We Value the Most Is Culture

April 25th 2025

NYOH’s Doyle on Joining OneOncology: What We Value the Most Is Culture

New York Oncology and Hematology becomes the 27th practice in OneOncology.

April 22nd 2025

New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix

Brooke McCormick Brady Post, PhD

On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.

Tailored approaches help patients with MM find the regimen that works best for them, which improves quality of life and outcomes | image credit: Dzmitry - stock.adobe.com

April 25th 2025

Tailored Dosing for MM Matters More Than Drug Count: Ajai Chari, MD

Kyle Munz Ajai Chari, MD

When it comes to treating multiple myeloma (MM), Ajai Chari, MD, argued that more is not always better. More intense treatment regimens, or those with more drugs, don't necessarily guarantee better outcomes.

Managed Care Cast Thumbnail

April 15th 2025

Personalized Care Key as Tirzepatide Use Expands Rapidly

Maggie L. Shaw John W. Ostrominski, MD

Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.

US Tariffs | Image credit: Andrii - stock.adobe.com

April 25th 2025

Trump Tariffs on Pharmaceuticals Risk Causing Higher Costs, Drug Shortages

The Trump administration is proceeding with probes into the national security implications of pharmaceutical imports.

Anatomy of colon model | Image credit: M+Isolation+Photo - stock.adobe.com

April 24th 2025

TyG-BMI Index Predicts Colorectal Cancer Risk, Study Finds

A new analysis links higher triglyceride-glucose (TyG) and TyG–body mass index (TyG-BMI) levels to increased colorectal cancer (CRC) risk, especially among women, but not mortality.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions